Cancer stem cells and radiotherapy: new insights into tumor radioresistance.
Diehn
Maximilian
M
Clarke
Michael F
MF
D000071916:AC133 Antigen; D000818:Animals; D015703:Antigens, CD / Q000378:metabolism; D014408:Biomarkers, Tumor / Q000378:metabolism; D001943:Breast Neoplasms / Q000473:pathology* / Q000532:radiotherapy*; D051927:CD24 Antigen / Q000378:metabolism; D004815:Epidermal Growth Factor / Q000378:metabolism; D005260:Female; D016222:Fibroblast Growth Factor 2 / Q000378:metabolism; D006023:Glycoproteins / Q000378:metabolism; D006801:Humans; D018960:Hyaluronan Receptors / Q000378:metabolism; D014411:Neoplastic Stem Cells / Q000528:radiation effects*; D010455:Peptides / Q000378:metabolism; D011836:Radiation Tolerance; D014407:Tumor Cells, Cultured
D000071916:AC133 Antigen; D015703:Antigens, CD; D014408:Biomarkers, Tumor; D051927:CD24 Antigen; D006023:Glycoproteins; D018960:Hyaluronan Receptors; D010455:Peptides; D016222:Fibroblast Growth Factor 2; D004815:Epidermal Growth Factor